1Mo·

Healthcare sector thus also covered and most convinced by J&J🙈🐵

10.09
Johnson&Johnson logo
Acheté x7 à 152,56 €
1 067,94 €
27
6 Commentaires

image de profil
For what reason J&J?
3
Voir toutes les 3 autres réponses
image de profil
Not every sector has to be covered. Pharma is difficult. You either have to be able to assess the pipeline quite well and still move in highly speculative spheres or you have enormously sporty valued companies in front of your nose or, as in the case of Johnson & Johnson, a blue chip portfolio brake with only moderate growth and the constant danger of slipping into some pharmaceutical scandal.
1
image de profil
J&j falls. Abott and Amgen are more stable
Participez à la conversation